Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,479 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Recruiting

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

NCT07233213

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Hacettepe University Faculty of Medicine Ankara, Altındağ, Turkey (Türkiye)
  • İnönü University Turgut Ozal Medical Center Training and Research Hospital Malatya, Battalgazi, Turkey (Türkiye)
  • İstanbul University, Istanbul Faculty of Medicine Istanbul, Fatih, Turkey (Türkiye)
  • Erciyes University Hematology Hospital Kayseri, Melikgazi, Turkey (Türkiye)
View Trial Details
Recruiting

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

NCT05500807

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +10 more
Locations
  • The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) Orange, California, United States
  • Stanford University: Stanford Children's Health Redwood City, California, United States
  • University of Miami - Miller School of Medicine Coral Gables, Florida, United States
  • St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders Tampa, Florida, United States
View Trial Details
Recruiting

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

NCT07115004

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Luskin Orthopaedic Institute For Children Los Angeles, California, United States
  • UC Davis Medical Center Sacramento, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

NCT07043946

Conditions
Anti-CD19, Autoimmune Diseases, Biologics, +20 more
Locations
  • Climb Bio Investigative Site #359202 Plovdiv, Bulgaria
  • Climb Bio Investigative Site #359203 Plovdiv, Bulgaria
  • Climb Bio Investigative Site #359201 Sofia, Bulgaria
  • Climb Bio Investigative Site #300204 Athens, Attica, Greece
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

NCT05936359

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations
  • Royal Brisbane and Women'S Hospital Herston, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter Maccallum Cancer Centre Melbourne, Victoria, Australia
  • The Alfred Hospital Melbourne, Victoria, Australia
View all 29 locations
View Trial Details
Recruiting

Monitoring of Anti-TFPI in Hemophilia

NCT07101926

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique Bron, France
  • Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso Paris, France
View Trial Details
Recruiting

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

NCT05198960

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +24 more
Locations
  • CHU d'Angers Angers, France
  • CH d'Annecy Annecy, France
  • CH d'Argenteuil Argenteuil, France
  • CH d'Avignon Avignon, France
View all 42 locations
View Trial Details

Related conditions